Trial Profile
Sirolimus-Eluting BX VELOCITY Balloon-Expandable Stent in a Compassionate Use Registry
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2010
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Coronary disorders
- Focus Therapeutic Use
- Acronyms SECURE
- Sponsors Cordis Corporation
- 15 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Dec 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 20 May 2008 New trial record.